Hoster E, Kluin-Nelemans H, Hermine O, et al. Rituximab Maintenance after First-Line Immunochemotherapy in Mantle Cell Lymphoma: Long-Term Follow-up of the Randomized European MCL Elderly Trial. ASH 59th Annual Meeting & Exhibition, abstract 153.
CD47-remmer Hu5F9-G4 plus rituximab bij non-hodgkinlymfoom
jan 2019 | Lymfoom